Jane Street’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Jane Street’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-13,831	Closed	-$234K	–	3772
2014 Q4	$234K	Sell	13,831 -313,260	-96%	-$4.41M	﹤0.01%	2091
2014 Q3	$3.9M	Buy	+327,091	New	+$2.23M	0.04%	349
2013 Q3	–	Sell	-108,013	Closed	-$497K	–	3499
2013 Q2	$497K	Buy	+108,013	New	+$371K	0.01%	1461

Jane Street's AVNR Position: Q1 2015 in Review

Jane Street sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 13,831 shares — an estimated $234K sold.

Jane Street first reported a position in AVNR in Q2 2013 and held it in 3 quarters. The position peaked at $3.9M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Jane Street reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Jane Street sold 13,831 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $234K.
Jane Street first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 3 quarters.
Jane Street's AVANIR PHARMACEUTICALS, INC CL A position peaked at $3.9M in Q3 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Jane Street's 13F filing for Q1 2015, filed 11 May 2015.